A detailed history of Kings Path Partners LLC transactions in Iradimed Corp stock. As of the latest transaction made, Kings Path Partners LLC holds 24,570 shares of IRMD stock, worth $1.39 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
24,570
Previous 24,008 2.34%
Holding current value
$1.39 Million
Previous $1.05 Billion 17.13%
% of portfolio
0.52%
Previous 0.5%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$43.23 - $50.29 $24,295 - $28,262
562 Added 2.34%
24,570 $1.24 Billion
Q2 2024

Jul 30, 2024

BUY
$40.36 - $44.7 $968,962 - $1.07 Million
24,008 New
24,008 $1.05 Billion

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $710M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Kings Path Partners LLC Portfolio

Follow Kings Path Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kings Path Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kings Path Partners LLC with notifications on news.